The weekly litigation news digest is live. Subscribe now

Roche Innovation Center Copenhagen competitive analysis

Loading summary...

Explore patent oppositions filed by Roche Innovation Center Copenhagen against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Dec 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Compositions And Methods For Modulating Gene ExpressionRANA THERAPEUTICSAug 2, 2019
Modulation Of Rna By Repeat TargetingIONIS PHARMACEUTICALSAug 13, 2018
Hbv Antisense InhibitorsGLAXO GROUPJul 10, 2018
Polycomb-Associated Non-Coding RnasTHE GENERAL HOSPITALFeb 13, 2018
Linkage Modified Gapped Oligomeric Compounds And Uses ThereofIONIS PHARMACEUTICALSFeb 2, 2018

Explore Roche Innovation Center Copenhagen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
Feb 12, 2020Antisense Design1

Latest PTAB cases involving Roche Innovation Center Copenhagen

Discover the latest PTAB cases involving Roche Innovation Center Copenhagen, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Roche Innovation Center Copenhagen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ROCHE372534
IONIS PHARMACEUTICALS117 - -
ISIS PHARMACEUTICALS - 9 - -
THE GENERAL HOSPITAL - 24 - 2